International Conference on Preventive Oncology (IC-PO-27)

This track focuses on the latest advancements in the development of preventive cancer vaccines. Participants will explore novel approaches and technologies that enhance vaccine efficacy and safety.

This session will delve into the role of immunotherapy in cancer treatment, emphasizing targeted gene therapy and its implications for patient outcomes. Discussions will include case studies and emerging research findings.

This track examines the mechanisms of action behind therapeutic cancer vaccines and their clinical applications. Experts will share insights on ongoing trials and the potential for personalized medicine.

Focusing on the development of DNA and protein-based vaccines, this session will highlight innovative research and its implications for cancer prevention and treatment. Participants will discuss challenges and future directions in this field.

This track will explore the concept of combination vaccines and their potential to enhance immune responses against cancer. Researchers will present findings on various combinations and their effectiveness.

This session addresses the unique challenges and strategies related to immunization in the geriatric population. Discussions will focus on the importance of tailored vaccine approaches for older adults at risk of cancer.

This track will engage participants in discussions about the ethical implications of cancer vaccine research and development. Topics will include informed consent, equity in access, and the role of regulatory bodies.

This session will focus on the importance of vaccines for pregnant women and neonates in preventing cancer-related diseases. Experts will discuss current research and the need for targeted immunization strategies.

This track will explore the emerging field of plant-derived vaccines and their potential applications in oncology. Participants will discuss the advantages and challenges of this innovative vaccine development strategy.

This session will investigate the development of vaccines for unconventional diseases, including their relevance to cancer prevention. Researchers will present novel findings and discuss future research directions.

This track will provide insights into the current landscape and future trends of the vaccine industry as it pertains to oncology. Discussions will include market dynamics, regulatory challenges, and opportunities for innovation.